Table 1 Summary of the demographic, clinical, and behavior of the two participant groups

Demographic profile

 Sex [F:M, n]

7:6

8:5

 Age* [mean ± std, year]

54 ± 11.6

56 ± 5.1

Medical profile

 Height [mean ± std, cm]

171 ± 11.1

167 ± 6.0

 Weight [mean ± std, kg]

75.6 ± 9.9

66.8 ± 15.1

 BMI [mean ± std, kg/m²]

26.0 ± 4.4

24.1 ± 4.6

 No. of Charlson comorbidity conditions in addition to cancer diagnosis [mean ± std]

1.2 ± 1.0

–

Oncological diagnosis

 Colon cancer [n]

11

–

 Rectal cancer [n]

2

–

Disease stages

–

 I

1

–

 II

0

–

 III

8

–

 IV

4

–

Chemotherapy

 Regimen

  Folfox

11

–

  Capox

1

–

  Folfoxiri

1

–

 Total dose [mean ± std (range), mg/m²]

763.8 ± 197.7 (1080–470)

–

 Time since last treatment [mean ± std (range), months]

7.7 ± 5.6 (0.3–19.9)

–

Behavioral profile

 Smoking [yes:no, n]

0:13

0:13

 Alcohol [yes:no, n]

9:4

8:5

  Weekly intake [mean ± std, alcohol unit]

4.4 ± 5.6

4.6 ± 4.8

 Physical activity^◊ [n]

  Light (activity score ≤ 6)

1

1

  Moderate (activity score 7–12)

5

3

  Heavy (activity score 13–18)

7

9